Expression and activity of potassium ion channels in human prostate cancer.

Four normal and 79 human prostate cancer (Pca) specimens were examined, by immunohistochemistry, for expression of voltage-gated potassium ion channels. Strong immunostaining (for Kv1.3) was observed in the normal and 47% (37/79) of Pca specimens. Twenty-nine percent (23/79) Pca specimens showed moderate and 24% (19/79) displayed low staining. Three potassium channel-openers at a concentration of 10 microg/mL, minoxidil (47.8 microM), 1-Ethyl-2-benzimidazolinone (EBIO) (61.7 microM) and diazoxide (43.3 microM), increased growth of PC3 cells by 30-50%. Potassium channel-blockers, dequalinium, amiodarone and glibenclamide, caused a dose-dependent, growth inhibition of four human Pca cell lines. Apoptosis occurred within 4h of treatment of PC3 cells with dequalinium (0.5 microg/mL, 0.9 microM), amiodarone (5 microg/mL, 7.3 microM) or glibenclamide (50 microg/mL, 0.1mM).

[1]  M. Djamgoz,et al.  Effects of voltage‐gated ion channel modulators on rat prostatic cancer cell proliferation: Comparison of strongly and weakly metastatic cell lines , 2000, The Prostate.

[2]  P. Coward,et al.  Study of the selective cytotoxic properties of cationic, lipophilic mitochondrial-specific compounds in gynecologic malignancies. , 1990, Gynecologic oncology.

[3]  D M Roden,et al.  Antiarrhythmic drugs: from mechanisms to clinical practice , 2000, Heart.

[4]  T. Wasada Adenosine triphosphate-sensitive potassium (K(ATP)) channel activity is coupled with insulin resistance in obesity and type 2 diabetes mellitus. , 2002, Internal medicine.

[5]  D. Strøbæk,et al.  Pharmacological characterization of small‐conductance Ca2+‐activated K+ channels stably expressed in HEK 293 cells , 2000, British journal of pharmacology.

[6]  W. Dai,et al.  A requirement for K+-channel activity in growth factor-mediated extracellular signal-regulated kinase activation in human myeloblastic leukemia ML-1 cells. , 1999, Blood.

[7]  Bonafé,et al.  Minoxidil upregulates the expression of vascular endothelial growth factor in human hair dermal papilla cells , 1998, The British journal of dermatology.

[8]  S. Pickering,et al.  Cell-cycle control of a large-conductance K+ channel in mouse early embryos , 1993, Nature.

[9]  S. Archer,et al.  Potassium channel diversity in vascular smooth muscle cells. , 1997, Canadian journal of physiology and pharmacology.

[10]  M. Djamgoz,et al.  Voltage‐gated K+ channel activity in human prostate cancer cell lines of markedly different metastatic potential: Distinguishing characteristics of PC‐3 and LNCaP cells , 2001, The Prostate.

[11]  J. Modica-Napolitano,et al.  Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells. , 2001, Advanced drug delivery reviews.

[12]  R. Greenberg,et al.  Phylogeny of ion channels: clues to structure and function. , 2001, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[13]  S. Rane The growth regulatory fibroblast IK channel is the prominent electrophysiological feature of rat prostatic cancer cells. , 2000, Biochemical and biophysical research communications.

[14]  B. Rudy,et al.  The Effects of Shaker β-Subunits on the Human Lymphocyte K+ Channel Kv1.3* , 1999, The Journal of Biological Chemistry.

[15]  T. Idziorek,et al.  YOPRO-1 permits cytofluorometric analysis of programmed cell death (apoptosis) without interfering with cell viability. , 1995, Journal of immunological methods.

[16]  V. Rybalchenko,et al.  Verapamil inhibits proliferation of LNCaP human prostate cancer cells influencing K+ channel gating. , 2001, Molecular pharmacology.

[17]  N. Prevarskaya,et al.  Potassium channels in rat prostate epithelial cells , 1999, FEBS letters.

[18]  J. Audin,et al.  Potassium conductance in the androgen‐sensitive prostate cancer cell line, LNCaP: Involvement in cell proliferation , 1997, The Prostate.

[19]  J. Simard,et al.  4‐aminopyridine causes apoptosis and blocks an outward rectifier K+ channel in malignant astrocytoma cell lines , 1997, Journal of neuroscience research.

[20]  A. Adeagbo 1-Ethyl-2-benzimidazolinone stimulates endothelial K(Ca) channels and nitric oxide formation in rat mesenteric vessels. , 1999, European journal of pharmacology.

[21]  W. Wonderlin,et al.  Mitogenic signal transduction in human breast cancer cells. , 1995, General pharmacology.

[22]  M. Cahalan,et al.  Ion Channel Phenotype of Melanoma Cell Lines , 1997, The Journal of Membrane Biology.

[23]  H. Kwan,et al.  Activity of voltage-gated K+ channels is associated with cell proliferation and Ca2+ influx in carcinoma cells of colon cancer. , 1999, Life sciences.

[24]  D. Spray,et al.  KATP Channels Regulate Mitogenically Induced Proliferation in Primary Rat Hepatocytes and Human Liver Cell Lines , 2000, The Journal of Biological Chemistry.

[25]  H. Sontheimer Voltage‐dependent ion channels in glial cells , 1994, Glia.

[26]  H. Korn,et al.  Ion channel blockers inhibit B cell activation at a precise stage of the G1 phase of the cell cycle. Possible involvement of K+ channels. , 1990, Journal of immunology.

[27]  Z. Shao,et al.  Preconditioning blocks cardiocyte apoptosis: Role of KATP channels and PKC-ε , 2002 .